• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于患有CDKL5缺乏症个体评估与管理的国际共识建议

International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

作者信息

Amin Sam, Monaghan Marie, Aledo-Serrano Angel, Bahi-Buisson Nadia, Chin Richard F, Clarke Angus J, Cross J Helen, Demarest Scott, Devinsky Orrin, Downs Jenny, Pestana Knight Elia M, Olson Heather, Partridge Carol-Anne, Stuart Graham, Trivisano Marina, Zuberi Sameer, Benke Tim A

机构信息

Department of Paediatric Neurology, Bristol Royal Hospital for Children, Bristol, United Kingdom.

Epilepsy Program, Department of Neurology, Ruber Internacional Hospital, Madrid, Spain.

出版信息

Front Neurol. 2022 Jun 20;13:874695. doi: 10.3389/fneur.2022.874695. eCollection 2022.

DOI:10.3389/fneur.2022.874695
PMID:35795799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9251467/
Abstract

CDKL5 Deficiency Disorder (CDD) is a rare, X-linked dominant condition that causes a developmental and epileptic encephalopathy (DEE). The incidence is between ~ 1:40,000 and 1:60,000 live births. Pathogenic variants in lead to seizures from infancy and severe neurodevelopmental delay. During infancy and childhood, individuals with CDD suffer impairments affecting cognitive, motor, visual, sleep, gastrointestinal and other functions. Here we present the recommendations of international healthcare professionals, experienced in CDD management, to address the multisystem and holistic needs of these individuals. Using a Delphi method, an anonymous survey was administered electronically to an international and multidisciplinary panel of expert clinicians and researchers. To provide summary recommendations, consensus was set, , as >70% agreement for responses. In the absence of large, population-based studies to provide definitive evidence for treatment, we propose recommendations for clinical management, influenced by this proposed threshold for consensus. We believe these recommendations will help standardize, guide and improve the medical care received by individuals with CDD.

摘要

CDKL5缺乏症(CDD)是一种罕见的X连锁显性疾病,可导致发育性癫痫性脑病(DEE)。发病率约为每40000至60000例活产中有1例。致病变异会导致婴儿期癫痫发作和严重的神经发育迟缓。在婴儿期和儿童期,患有CDD的个体在认知、运动、视觉、睡眠、胃肠道及其他功能方面存在障碍。在此,我们展示了在CDD管理方面经验丰富的国际医疗专业人员的建议,以满足这些个体的多系统和整体需求。采用德尔菲法,通过电子方式对国际多学科专家临床医生和研究人员小组进行了匿名调查。为了提供总结性建议,设定了共识标准,即对于回复的同意率>70%。由于缺乏大规模的基于人群的研究来为治疗提供确凿证据,我们根据这一共识提议阈值,提出临床管理建议。我们相信这些建议将有助于规范、指导和改善CDD患者所接受的医疗护理。

相似文献

1
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.关于患有CDKL5缺乏症个体评估与管理的国际共识建议
Front Neurol. 2022 Jun 20;13:874695. doi: 10.3389/fneur.2022.874695. eCollection 2022.
2
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.为 CDKL5 缺乏症患者提供优质护理:欧洲专家小组对患者就医旅程的意见。
Epilepsia Open. 2024 Jun;9(3):832-849. doi: 10.1002/epi4.12914. Epub 2024 Mar 7.
3
CDKL5 Deficiency DisorderCDKL5缺陷障碍
4
Deletions in the CDKL5 5' untranslated region lead to CDKL5 deficiency disorder.CDKL5基因5'非翻译区的缺失会导致CDKL5缺乏症。
Am J Med Genet A. 2025 Jan;197(1):e63843. doi: 10.1002/ajmg.a.63843. Epub 2024 Aug 28.
5
Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.探讨患有严重发育性和癫痫性脑病、CDKL5 缺乏症个体的生活质量。
Epilepsy Res. 2021 Jan;169:106521. doi: 10.1016/j.eplepsyres.2020.106521. Epub 2020 Dec 1.
6
CDKL5 deficiency disorder in males: Five new variants and review of the literature.男性 CDKL5 缺乏症:五个新变异体及文献复习。
Eur J Paediatr Neurol. 2021 Jul;33:9-20. doi: 10.1016/j.ejpn.2021.04.007. Epub 2021 Apr 30.
7
CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism.CDKL5 缺乏症导致癫痫发作,与细胞嵌合体无关。
J Neurol Sci. 2022 Dec 15;443:120498. doi: 10.1016/j.jns.2022.120498. Epub 2022 Nov 16.
8
CDKL5 Deficiency Disorder (CDD)-Rare Presentation in Male.CDKL5缺乏症(CDD)——男性中的罕见表现。
Children (Basel). 2022 Nov 24;9(12):1806. doi: 10.3390/children9121806.
9
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of Deficiency Disorder.用 GSK-3β/HDAC 双重抑制剂治疗可恢复缺陷疾病的体外和体内模型中的神经元存活和成熟。
Int J Mol Sci. 2021 May 31;22(11):5950. doi: 10.3390/ijms22115950.
10
A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.了解 CDKL5 缺乏症患者生活质量领域的框架。
Am J Med Genet A. 2019 Feb;179(2):249-256. doi: 10.1002/ajmg.a.61012. Epub 2018 Dec 18.

引用本文的文献

1
CDKL5 Deficiency Disorder: Revealing the Molecular Mechanism of Pathogenic Variants.CDKL5缺陷障碍:揭示致病变异的分子机制
Int J Mol Sci. 2025 Aug 29;26(17):8399. doi: 10.3390/ijms26178399.
2
Caregivers' Perceptions of Clinical Symptoms, Disease Management, and Quality of Life Impact in Cases of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Cross-Sectional Online Survey.细胞周期蛋白依赖性激酶样5缺乏症患者的照料者对临床症状、疾病管理及生活质量影响的认知:横断面在线调查
JMIR Form Res. 2025 Jun 10;9:e72489. doi: 10.2196/72489.
3
Natural language processing and expert follow-up establishes tachycardia association with CDKL5 deficiency disorder.

本文引用的文献

1
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial.甘氨酰单钠在 CDKL5 缺乏症患者中的安全性和疗效:一项随机、双盲、安慰剂对照、3 期临床试验的双盲期结果。
Lancet Neurol. 2022 May;21(5):417-427. doi: 10.1016/S1474-4422(22)00077-1.
2
Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.CDKL5 缺乏症相关脑性视觉障碍与发育成就相关。
J Child Neurol. 2021 Oct;36(11):974-980. doi: 10.1177/08830738211019284.
3
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.
自然语言处理和专家随访确定了心动过速与CDKL5缺乏症之间的关联。
Genet Med Open. 2023 Nov 18;2:100842. doi: 10.1016/j.gimo.2023.100842. eCollection 2024.
4
Deletions in the CDKL5 5' untranslated region lead to CDKL5 deficiency disorder.CDKL5基因5'非翻译区的缺失会导致CDKL5缺乏症。
Am J Med Genet A. 2025 Jan;197(1):e63843. doi: 10.1002/ajmg.a.63843. Epub 2024 Aug 28.
5
Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database.国际数据库中 CDKL5 缺乏症患者照顾者对抗癫痫药物的获益和副作用的看法。
CNS Drugs. 2024 Sep;38(9):719-732. doi: 10.1007/s40263-024-01105-z. Epub 2024 Jul 26.
6
Early Developmental Intervention and Enriched Environment in CDKL5 Developmental and Epileptic Encephalopathy: A Case Report.CDKL5 发育性和癫痫性脑病的早期发育干预与丰富环境:一例报告
Neurol Clin Pract. 2024 Jun;14(3):e200287. doi: 10.1212/CPJ.0000000000200287. Epub 2024 Apr 19.
7
Gut microbiota profile in CDKL5 deficiency disorder patients.CDKL5 缺乏症患者的肠道微生物群特征。
Sci Rep. 2024 Mar 28;14(1):7376. doi: 10.1038/s41598-024-56989-0.
8
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.为 CDKL5 缺乏症患者提供优质护理:欧洲专家小组对患者就医旅程的意见。
Epilepsia Open. 2024 Jun;9(3):832-849. doi: 10.1002/epi4.12914. Epub 2024 Mar 7.
9
CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description.CDKL5 缺乏症:首例描述 20 年后的一些经验教训。
Am J Intellect Dev Disabil. 2024 Mar 1;129(2):101-109. doi: 10.1352/1944-7558-129.2.101.
10
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System.用于治疗癫痫发作和癫痫的新型 GABA 靶向治疗药物:I. GABA 作为癫痫活动调节剂的作用,以及最近批准的作用于 GABA 系统的药物。
CNS Drugs. 2023 Sep;37(9):755-779. doi: 10.1007/s40263-023-01027-2. Epub 2023 Aug 21.
CDKL5 缺乏症的当前神经治疗和新兴疗法。
J Neurodev Disord. 2021 Sep 16;13(1):40. doi: 10.1186/s11689-021-09384-z.
4
Correction to: Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG).对以下内容的更正:孕期和孕前常染色体隐性和X连锁疾病的筛查:美国医学遗传学与基因组学学会(ACMG)的实践资源。
Genet Med. 2021 Oct;23(10):2015. doi: 10.1038/s41436-021-01300-z.
5
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder.用于评估 CDKL5 缺乏症严重程度的临床报告项目的内容验证。
J Child Neurol. 2021 Oct;36(11):998-1006. doi: 10.1177/08830738211019576. Epub 2021 Aug 11.
6
Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder.芬氟拉明对 CDKL5 缺乏症癫痫发作的影响。
Epilepsia. 2021 Jul;62(7):e98-e102. doi: 10.1111/epi.16923. Epub 2021 May 12.
7
Sodium channel blockers for the treatment of epilepsy in CDKL5 deficiency disorder: Findings from a multicenter cohort.钠离子通道阻滞剂治疗 CDKL5 缺乏症相关癫痫:一项多中心队列研究结果。
Epilepsy Behav. 2021 May;118:107946. doi: 10.1016/j.yebeh.2021.107946. Epub 2021 Apr 10.
8
Gastrostomy Tubes Placed in Children With Neurologic Impairment: Associated Morbidity and Mortality.神经功能障碍患儿胃造口管的放置:相关发病率和死亡率。
J Child Neurol. 2021 Aug;36(9):727-734. doi: 10.1177/08830738211000179. Epub 2021 Mar 22.
9
Eye-trackers, digital-libraries, and print-referencing: A single case study in CDKL5.眼动追踪器、数字图书馆和参考文献:CDKL5 中的单个案例研究。
Res Dev Disabil. 2021 May;112:103913. doi: 10.1016/j.ridd.2021.103913. Epub 2021 Feb 21.
10
Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.利用国际数据集探索 CDKL5 缺乏症的基因型-表型关系。
Clin Genet. 2021 Jan;99(1):157-165. doi: 10.1111/cge.13862. Epub 2020 Oct 20.